AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wagner, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wagner, W.
Related Collections
Right arrow Other Race/Ethnicity
Right arrow Socioeconomic Factors
Right arrow Urban Health
July 2005, Vol 95, No. S1 | American Journal of Public Health S99-S106
© 2005 American Public Health Association
DOI: 10.2105/AJPH.2004.044792

PUBLIC HEALTH MATTERS

The Perils of Relying on Interested Parties to Evaluate Scientific Quality

Wendy Wagner, JD, MES

The author is with the University of Texas School of Law, Austin.

Correspondence: Request for reprints should be sent to Wendy Wagner, University of Texas School of Law, 727 East Dean Keeton Street, Austin, TX 78705-3299 (e-mail: wwagner{at}mail.law.utexas.edu).

Recently, there has been a trend in both civil litigation and regulatory law to circumvent the scientific community’s collective judgment on the quality of individual studies with an adversarial process of evaluating scientific quality using interest groups. The Supreme Court’s Daubert v Merrell Dow Pharmaceuticals, Inc opinion and two recent "good science" laws passed by Congress adopt an adversarial process informed by affected parties for reviewing and screening scientific quality. These developments are unwise. Both theory and experience instruct that an adversarial, interest group–dominated approach to evaluating scientific quality will lead to the unproductive deconstruction of science, further blur the distinction between policy and scientific judgments, and result in poor decisions because the courts and agencies that preside over these "good science" contests sometimes lack the scientific competency needed to make sound decisions.




This article has been cited by other articles:


Home page
 JAMAHome page
L. Rosenstock
Protecting special interests in the name of "good science".
JAMA, May 24, 2006; 295(20): 2407 - 2410.
[Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
E. Bingham, L. Boden, R. Clapp, P. Hoppin, S. Krimsky, D. Michaels, D. Ozonoff, and A. Robbins
BINGHAM ET AL. RESPOND
Am J Public Health, February 1, 2006; 96(2): 206 - 207.
[Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
D. Michaels
Scientific Evidence and Public Policy
Am J Public Health, July 1, 2005; 95(S1): S5 - S7.
[Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
P. J. Hoppin and R. Clapp
Science and Regulation: Current Impasse and Future Solutions
Am J Public Health, July 1, 2005; 95(S1): S8 - S12.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
R. L. Melnick
A Daubert Motion: A Legal Strategy to Exclude Essential Scientific Evidence in Toxic Tort Litigation
Am J Public Health, July 1, 2005; 95(S1): S30 - S34.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Public Health Association